Thomas Witzig
Professor of Medicine · Mayo Clinic College of Medicine and Science
Credentials: · · · · ·
History
- 1982–1985
Department of Internal Medicine University of Iowa Hospitals and Clinics
Research
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
New England Journal of Medicine · 2017 · 4,914 citations
Review of 1027 patients with newly diagnosed multiple myeloma
Mayo Clinic Proceedings · 2003 · 1,719 citations
Targeting apoptosis pathways in cancer therapy
Review · Current Anthropology · 2005 · 1,052 citations
199 papers
198 papers
- GN
125 papers · 2 as a fellow
124 papers
- RK
109 papers
- ML
105 papers
- SR
100 papers
91 papers
Grants
- 2002–2023
Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer
National Cancer Institute · P50
PI · $19.9M · University of Iowa
- 2007–2014
Signal Transduction Inhibitor Therapy for Lymphoma
National Cancer Institute · R01
Contact PI · $1.7M · Mayo Clinic Rochester
- 2005–2009
PI3K Pathway Inhibitors for Mantle Cell Lymphoma
National Cancer Institute · R21
Contact PI · $495.9K · Mayo Clinic Rochester
- 2001–2006
Radioimmunotherapy for Lymphoma
National Cancer Institute · R21
Contact PI · $504.7K · Mayo Clinic Rochester
Clinical trials
- 2022–2027
Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma
Principal investigator · Recruiting · Early phase 1
Mayo Clinic
- 2018–2033
Principal investigator · Recruiting · Phase 2
Mayo Clinic
- 2016–2019
Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma
Principal investigator · Completed
Mayo Clinic
- 2015–2023
Principal investigator · Terminated · Phase 3
Mayo Clinic